Andrew Medvec

911 total citations
8 papers, 736 citations indexed

About

Andrew Medvec is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Andrew Medvec has authored 8 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 2 papers in Genetics. Recurrent topics in Andrew Medvec's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). Andrew Medvec is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers) and CAR-T cell therapy research (3 papers). Andrew Medvec collaborates with scholars based in United States and United Kingdom. Andrew Medvec's co-authors include James L. Riley, Hong Kong, Angel Varela‐Rohena, Fang Wei, Zhengyu Ma, Gordon J. Freeman, Michelle Krogsgaard, Rafi Ahmed, Zhong Shi and Gabriela Plesa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and American Journal Of Pathology.

In The Last Decade

Andrew Medvec

8 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Medvec United States	8	455	326	134	103	87	8	736
Julie Dierksheide United States	13	629 1.4×	412 1.3×	147 1.1×	44 0.4×	103 1.2×	14	943
W. Herr Germany	19	507 1.1×	282 0.9×	194 1.4×	53 0.5×	192 2.2×	32	846
Michelle A. Neller Australia	18	627 1.4×	490 1.5×	223 1.7×	120 1.2×	226 2.6×	33	992
Gareth Betts United Kingdom	15	672 1.5×	385 1.2×	148 1.1×	157 1.5×	82 0.9×	19	924
Motoko Koyama Australia	18	874 1.9×	188 0.6×	200 1.5×	64 0.6×	68 0.8×	24	1.2k
Dominik Schneidawind Germany	21	609 1.3×	303 0.9×	430 3.2×	36 0.3×	59 0.7×	57	1.2k
Benoît Vingert France	17	460 1.0×	77 0.2×	155 1.2×	125 1.2×	146 1.7×	39	916
Qingyu Cheng Germany	14	485 1.1×	117 0.4×	134 1.0×	73 0.7×	65 0.7×	25	857
Xiaochuan Shan United States	12	372 0.8×	235 0.7×	356 2.7×	90 0.9×	49 0.6×	20	779
Elisabeth Calderón‐Gómez Germany	9	717 1.6×	94 0.3×	132 1.0×	63 0.6×	89 1.0×	11	900

Countries citing papers authored by Andrew Medvec

Since Specialization

Citations

This map shows the geographic impact of Andrew Medvec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Medvec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Medvec more than expected).

Fields of papers citing papers by Andrew Medvec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Medvec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Medvec. The network helps show where Andrew Medvec may publish in the future.

Co-authorship network of co-authors of Andrew Medvec

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Medvec. A scholar is included among the top collaborators of Andrew Medvec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Medvec. Andrew Medvec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wyatt, Megan M., Michelle H. Nelson, Andrew Medvec, et al.. (2023). Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells. Molecular Therapy. 31(7). 2120–2131. 10 indexed citations

2.

Guo, Lili, Luis Gil‐de‐Gómez, Andrew Medvec, et al.. (2018). Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Reports. 23(3). 741–755. 47 indexed citations

3.

Medvec, Andrew, et al.. (2017). Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium. Molecular Therapy — Methods & Clinical Development. 8. 65–74. 45 indexed citations

4.

Putnam, Amy, Niloufar Safinia, Andrew Medvec, et al.. (2013). Clinical Grade Manufacturing of Human Alloantigen-Reactive Regulatory T Cells for Use in Transplantation. American Journal of Transplantation. 13(11). 3010–3020. 209 indexed citations

5.

Wei, Fang, Zhong Shi, Zhengyu Ma, et al.. (2013). Strength of PD-1 signaling differentially affects T-cell effector functions. Proceedings of the National Academy of Sciences. 110(27). E2480–9. 230 indexed citations

6.

Zhang, Qian, Fang Wei, Hong Yi Wang, et al.. (2013). The Potent Oncogene NPM-ALK Mediates Malignant Transformation of Normal Human CD4+ T Lymphocytes. American Journal Of Pathology. 183(6). 1971–1980. 27 indexed citations

7.

Plesa, Gabriela, Lingjie Zheng, Andrew Medvec, et al.. (2012). TCR affinity and specificity requirements for human regulatory T-cell function. Blood. 119(15). 3420–3430. 48 indexed citations

8.

Francica, Joseph R., Angel Varela‐Rohena, Andrew Medvec, et al.. (2010). Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein. PLoS Pathogens. 6(9). e1001098–e1001098. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact